文献速递间质性肺疾病

弥漫性囊性肺疾病:识别与管理的临床指南

Diffuse Cystic Lung Disease: A Clinical Guide to Recognition and Management.
PubMed 文献 · Chest · 2024-08-19

本文为综述,提供弥漫性囊性肺疾病(DCLD)的实用评估框架,聚焦淋巴管肌瘤病、肺朗格汉斯细胞组织细胞增生症、Birt-Hogg-Dubé综合征和淋巴细胞性间质性肺炎。胸部CT是识别DCLD最有价值的无创诊断手段,结合结构化病史与肾、皮肤表现可提高诊断率。早期识别有助于及时干预并降低病死率。

要点

  • DCLD以多发薄壁肺囊腔为共同影像表型,属异质性实体,需与纤维炎性间质性肺病区分。
  • 胸部CT是识别DCLD最有价值的无创诊断方法,应作为核心检查。
  • 结构化采集病史(医疗、社会、家族史)及肾脏、皮肤表现可提高诊断率。

核心结论

  • DCLD虽各病种罕见,但总体在临床中并不少见,肺科医生应提高识别能力。
  • 采用实用且系统的临床评估与检查流程,可改善病例发现、实现早期干预并降低病死率。

研究设计与样本

  • 综述类文章,旨在为肺科医生提供DCLD的实用评估框架与当前诊断管理方法。

主要发现

  • DCLD在流行病学、临床表现、分子发病机制和治疗方面不同于典型纤维炎性间质性肺病,值得独立分类。
  • 部分DCLD已有靶向治疗发现,凸显及时准确识别对患者管理的重要性。
  • 胸部CT是识别DCLD最有价值的无创诊断手段。
  • 结构化评估高产出相关因素(如医疗、社会、家族史及肾脏和皮肤表现)可提高诊断可能性。

关键数值与推荐

  • 重点讨论肺科医生最可能遇到的DCLD:淋巴管肌瘤病、肺朗格汉斯细胞组织细胞增生症、Birt-Hogg-Dubé综合征和淋巴细胞性间质性肺炎。

临床怎么用

  • 对疑似DCLD患者首选胸部CT进行无创评估。
  • 系统采集医疗、社会、家族史并检查肾脏和皮肤表现,以提高诊断率。
  • 提高对DCLD的识别意识,以便早期干预并降低 morbidity 和 mortality。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

TOPIC IMPORTANCE: Diffuse cystic lung diseases (DCLDs) represent a group of pathophysiologically heterogeneous entities that share a common radiologic phenotype of multiple thin-walled pulmonary cysts. DCLDs differ from the typical fibroinflammatory interstitial lung diseases in their epidemiology, clinical presentation, molecular pathogenesis, and therapeutic approaches, making them worthy of a distinct classification. The importance of timely and accurate identification of DCLDs is heightened by the impact on patient management including recent discoveries of targeted therapeutic approaches for some disorders. REVIEW FINDINGS: This article offers a practical framework for evaluating patients with DCLD, indicating the most appropriate and current diagnostic and management approaches. We focus on the DCLDs that are most likely to be encountered by practicing pulmonologists: lymphangioleiomyomatosis, pulmonary Langerhans cell histiocytosis, Birt-Hogg-Dubé syndrome, and lymphoid interstitial pneumonia. Chest CT scan is the most informative noninvasive diagnostic modality to identify DCLDs. Thereafter, instituting a structured approach to high-yield associated factors (eg, medical, social, and family history; renal and dermatologic findings) increases the likelihood of identifying DCLDs and achieving a diagnosis. SUMMARY: Although the individual diseases that comprise the DCLD family are rare, taken together, DCLDs can be encountered more frequently in clinical practice than commonly perceived. An increased eagerness among general pulmonary physicians to recognize these entities, coupled with a practical and systematic clinical approach to examinations and investigations, is required to improve case findings, allow earlier intervention, and reduce morbidity and mortality.

来源:Chest,查看原文。版权归原作者所有。

引用

  1. Franciosi AN, Gupta N, Murphy DJ, et al. Diffuse Cystic Lung Disease: A Clinical Guide to Recognition and Management. Chest. 2024. PMID: 39168181. doi:10.1016/j.chest.2024.08.008

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。